While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.
According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research.
In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More
Medable Unveils Generative AI to Accelerate Clinical Trial Startup
What You Should Know:
- Medable Inc., a leader in clinical development technology, has announced Medable AI, a suite of generative AI capabilities designed to revolutionize the clinical trial startup process. Medable AI empowers sponsors and clinical research organizations (CROs) to build digital and decentralized trials faster, with greater efficiency and control.
- The launch of Medable AI is part of a broader AI strategy for Medable, with plans to expand AI capabilities across its
Read More
Japan’s National Cancer Center Selects Paradigm for Nationwide Clinical Trial Network
What You Should Know:
- A new cancer treatment and research era is dawning in Japan with the launch of LC-SCRUM-CD (Lung Cancer Genome Screening Project for Individualized Medicine - Clinical Development).
- The nationwide clinical trial network is a collaborative effort between the National Cancer Center (NCC), Precision Medicine Asia Co., Ltd. (PREMIA), and Paradigm Health Inc. (Paradigm).
Building on LC-SCRUM-Asia's Foundation
LC-SCRUM-CD expands upon the existing
Read More
Starget Pharma Secures $5.1M for AI-Powered Targeted Radiotherapy for Cancer
What You Should Know:
- Starget Pharma, an innovative startup specializing in precision cancer diagnostics and targeted radiotherapy, has secured $5.1M in funding from Cancer Focus, a fund established in collaboration with the renowned MD Anderson Cancer Center.
- The investment will support Starget Pharma's upcoming clinical trial for treating advanced metastatic cancers, including sarcomas, neuroendocrine tumors, melanoma, and liver cancer.
Revolutionizing Cancer Treatment
Read More
H1 Expands Trial Landscape Platform with UK Diversity Data and AI-Powered Site Rescue
What You Should Know:
- H1, a provider of healthcare data and analytics, has announced significant enhancements to its Trial Landscape platform.
- These updates include the integration of diversity data for over 34 million patients in England and the launch of an AI-powered Site Rescue functionality, both designed to accelerate equitable clinical trials and improve research outcomes.
Addressing Diversity in Clinical Trials
Diversity, equity, and inclusion (DEI) are
Read More
Medable Partners with Google Cloud to Accelerate Clinical Trials
What You Should Know:
- Medable Inc., a provider of decentralized and hybrid clinical trial solutions, is collaborating with Google Cloud to make its Digital and Decentralized Clinical Trial Platform available on the Google Cloud Marketplace.
- The strategic partnership will empower life sciences companies to accelerate clinical development by leveraging Google Cloud's cutting-edge infrastructure and AI capabilities.
Streamlining Clinical Trials with Medable and Google
Read More
Abbott Launches Clinical Trial to Optimize Heart Failure Treatment with AI-Powered Monitoring
What You Should Know:
- Abbott, a global healthcare leader, has announced a new clinical trial, TEAM-HF, designed to improve outcomes for patients with worsening heart failure.
- The first-of-its-kind trial will leverage AI and Abbott's CardioMEMS™ HF System to identify patients who may benefit from earlier intervention with advanced therapies, such as a HeartMate 3™ left ventricular assist device (LVAD).
Addressing the Challenges of Advanced Heart Failure
Heart
Read More
How A Human-AI Partnership Can Boost Clinical Trial Recruitment
The demand for clinical trial testing is rising, from over 260,000 trials conducted in 2018 to nearly double that figure in 2024. This means that more trials are being conducted simultaneously than ever—a factor that adds to the already challenging process of finding clinical trial participants.
Because trial sponsors are struggling to find sufficient numbers of suitable participants, 80% of the world’s more than 450,000 clinical trials are at risk of
Read More
5 Ways Tech is Enhancing Patient Engagement in Clinical Trials
Patient engagement is critical on several levels. It helps inform updates to trial design and processes, it ensures critical data is collected to determine the safety and efficacy of an investigational product, and it supports patient retention for the duration of the trial. That’s why biopharma sponsors and research sites are leaning into technology to facilitate this engagement. It’s important for physicians and other healthcare professionals to be aware of this technology and how it can
Read More
